Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT00274703
First received: January 10, 2006
Last updated: December 2, 2016
Last verified: December 2016